These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1854173)

  • 1. In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivatives.
    Hardy DJ; Swanson RN; Shipkowitz NL; Freiberg LA; Lartey PA; Clement JJ
    Antimicrob Agents Chemother; 1991 May; 35(5):922-8. PubMed ID: 1854173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
    Fernandes PB; Bailer R; Swanson R; Hanson CW; McDonald E; Ramer N; Hardy D; Shipkowitz N; Bower RR; Gade E
    Antimicrob Agents Chemother; 1986 Dec; 30(6):865-73. PubMed ID: 2949695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
    Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
    J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.
    Hardy DJ; Swanson RN; Rode RA; Marsh K; Shipkowitz NL; Clement JJ
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1407-13. PubMed ID: 2143642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of sparfloxacin in Legionella infections.
    Saito A; Gaja M
    Drugs; 1995; 49 Suppl 2():250-2. PubMed ID: 8549320
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Peters DH; Clissold SP
    Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
    Girard AE; Girard D; English AR; Gootz TD; Cimochowski CR; Faiella JA; Haskell SL; Retsema JA
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1948-54. PubMed ID: 2830841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease.
    Fitzgeorge RB; Lever S; Baskerville A
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():171-6. PubMed ID: 8396090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides.
    Bright GM; Nagel AA; Bordner J; Desai KA; Dibrino JN; Nowakowska J; Vincent L; Watrous RM; Sciavolino FC; English AR
    J Antibiot (Tokyo); 1988 Aug; 41(8):1029-47. PubMed ID: 3139603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activities of C-21 functionalized derivatives of (9R)-9-amino-9-deoxoerythromycins A and B.
    Lartey PA; DeNinno SL; Faghih R; Hardy DJ; Clement JJ; Plattner JJ; Stephens RL
    J Med Chem; 1991 Dec; 34(12):3390-5. PubMed ID: 1766004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol.
    Fitzgeorge RB; Featherstone AS; Baskerville A
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():101-8. PubMed ID: 2154427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Weiss WJ; Edelstein MA
    Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis.
    Dournon E; Rajagopalan P; Vilde JL; Pocidalo JJ
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():41-8. PubMed ID: 3458697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents.
    Floyd-Reising S; Hindler JA; Young LS
    Antimicrob Agents Chemother; 1987 Apr; 31(4):640-2. PubMed ID: 2955742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of erythromycin in a general practice.
    Grob PR
    Scott Med J; 1977 Dec; 22(5):405-7. PubMed ID: 601560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporeamicin A, a new macrolide antibiotic. III. Biological properties.
    Morishita A; Mutoh N; Ishizawa K; Suzuki T; Yokoiyama S; Yaginuma S
    J Antibiot (Tokyo); 1992 May; 45(5):613-7. PubMed ID: 1624362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH; Shinzato T; Edelstein MA
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.